ES2121389T3 - Derivados de alquildiamina sustituidos y su uso como antagonistas de taquiquinina. - Google Patents

Derivados de alquildiamina sustituidos y su uso como antagonistas de taquiquinina.

Info

Publication number
ES2121389T3
ES2121389T3 ES95920539T ES95920539T ES2121389T3 ES 2121389 T3 ES2121389 T3 ES 2121389T3 ES 95920539 T ES95920539 T ES 95920539T ES 95920539 T ES95920539 T ES 95920539T ES 2121389 T3 ES2121389 T3 ES 2121389T3
Authority
ES
Spain
Prior art keywords
sub
antagonists
taquiquinine
useful
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95920539T
Other languages
English (en)
Spanish (es)
Inventor
Timothy P Burkholder
Elizabeth Kudlacz
Tieu-Binh Le
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2121389T3 publication Critical patent/ES2121389T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/64Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/78Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/52Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the nitrogen atom of at least one of the carboxamide groups further acylated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
ES95920539T 1994-06-20 1995-05-19 Derivados de alquildiamina sustituidos y su uso como antagonistas de taquiquinina. Expired - Lifetime ES2121389T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/262,209 US5597845A (en) 1994-06-20 1994-06-20 Substituted alkyldiamine derivatives

Publications (1)

Publication Number Publication Date
ES2121389T3 true ES2121389T3 (es) 1998-11-16

Family

ID=22996631

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95920539T Expired - Lifetime ES2121389T3 (es) 1994-06-20 1995-05-19 Derivados de alquildiamina sustituidos y su uso como antagonistas de taquiquinina.

Country Status (20)

Country Link
US (1) US5597845A (cg-RX-API-DMAC7.html)
EP (1) EP0767783B1 (cg-RX-API-DMAC7.html)
JP (1) JP3920916B2 (cg-RX-API-DMAC7.html)
KR (1) KR100371981B1 (cg-RX-API-DMAC7.html)
CN (1) CN1083429C (cg-RX-API-DMAC7.html)
AT (1) ATE169905T1 (cg-RX-API-DMAC7.html)
AU (1) AU691619B2 (cg-RX-API-DMAC7.html)
CA (1) CA2193348C (cg-RX-API-DMAC7.html)
DE (1) DE69504198T2 (cg-RX-API-DMAC7.html)
DK (1) DK0767783T3 (cg-RX-API-DMAC7.html)
ES (1) ES2121389T3 (cg-RX-API-DMAC7.html)
FI (1) FI115135B (cg-RX-API-DMAC7.html)
HU (1) HUT75965A (cg-RX-API-DMAC7.html)
IL (1) IL114185A (cg-RX-API-DMAC7.html)
MX (1) MX9606654A (cg-RX-API-DMAC7.html)
NO (1) NO307458B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ287291A (cg-RX-API-DMAC7.html)
TW (1) TW442451B (cg-RX-API-DMAC7.html)
WO (1) WO1995035279A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA954947B (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW541295B (en) * 1999-01-05 2003-07-11 Nippon Zoki Pharmaceutical Co A novel substituted alkylteraamine derivative for use as tachykinin antagonist
US6613801B2 (en) * 2000-05-30 2003-09-02 Transtech Pharma, Inc. Method for the synthesis of compounds of formula I and their uses thereof
JP2004523565A (ja) 2001-03-05 2004-08-05 トランス テック ファーマ,インコーポレイテッド 治療因子としてのベンゾイミダゾール誘導体
CN1494425B (zh) 2001-03-05 2011-12-07 特兰斯泰克制药公司 用作治疗剂的羧酰胺衍生物
ATE529110T1 (de) 2002-03-05 2011-11-15 Transtech Pharma Inc Mono- und bicyclische azolderivate die die interaktion von liganden mit rage hemmen
US20090263370A1 (en) * 2006-11-30 2009-10-22 Guoliang Tao Methods for treating tachykinin-mediated diseases with cholinesterase
TWI517850B (zh) 2009-09-30 2016-01-21 Vtv治療有限責任公司 經取代之咪唑衍生物及其使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164372A (en) * 1989-04-28 1992-11-17 Fujisawa Pharmaceutical Company, Ltd. Peptide compounds having substance p antagonism, processes for preparation thereof and pharmaceutical composition comprising the same
WO1994004494A1 (en) * 1992-08-13 1994-03-03 Warner-Lambert Company Tachykinin antagonists
EP0593559A1 (en) * 1991-07-05 1994-04-27 MERCK SHARP & DOHME LTD. Aromatic compounds, pharmaceutical compositions containing them and their use in therapy

Also Published As

Publication number Publication date
NO307458B1 (no) 2000-04-10
DK0767783T3 (da) 1999-05-25
FI115135B (fi) 2005-03-15
TW442451B (en) 2001-06-23
ATE169905T1 (de) 1998-09-15
JP3920916B2 (ja) 2007-05-30
NZ287291A (en) 1998-10-28
IL114185A (en) 1999-07-14
WO1995035279A1 (en) 1995-12-28
HU9603540D0 (en) 1997-02-28
DE69504198T2 (de) 1999-04-29
CA2193348C (en) 1999-08-24
NO965469L (no) 1997-02-19
AU2596195A (en) 1996-01-15
MX9606654A (es) 1997-12-31
CA2193348A1 (en) 1995-12-28
KR100371981B1 (ko) 2003-06-12
US5597845A (en) 1997-01-28
JPH10501551A (ja) 1998-02-10
CN1083429C (zh) 2002-04-24
EP0767783A1 (en) 1997-04-16
IL114185A0 (cg-RX-API-DMAC7.html) 1995-10-31
ZA954947B (en) 1996-01-31
AU691619B2 (en) 1998-05-21
EP0767783B1 (en) 1998-08-19
CN1155883A (zh) 1997-07-30
NO965469D0 (no) 1996-12-19
FI965097L (fi) 1996-12-18
HUT75965A (en) 1997-05-28
FI965097A0 (fi) 1996-12-18
DE69504198D1 (de) 1998-09-24

Similar Documents

Publication Publication Date Title
DE60220422D1 (de) Substituierte pyrazoloverbindungen zur behandlung von entzündungen
ES2158345T3 (es) Derivados de piperazino como antagonistas de la neuroquinina.
ES2162061T3 (es) Derivados de piperidina como antagonistas de la neuroquinina.
KR860005001A (ko) 세제 조성물
GT200100160A (es) Derivados 4-fenil-piridina.
ES2164657T3 (es) Derivados aza-biciclicos puenteados como antagonistas de la sustancia p.
ES2126566T3 (es) 1-arilpirazoles plaguicidas.
ES2147759T3 (es) Heterociclos no aromaticos sustituidos con aminometileno y uso como antagonistas de la sustancia p.
ES2158814A1 (es) Antagonistas iii del receptor ccr-3.
EA200300171A1 (ru) Циклопентаноиндолы, композиции, содержащие данные соединения, и способы лечения
BG103964A (en) SUBSTITUTED PYRAZOLS AS p38 KINASE INHIBITORS
ES2194314T3 (es) Derivados de benzopirano sustituidos para el tratamiento de inflamaciones.
ATE469892T1 (de) Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung
ES2154686T3 (es) Compuestos de piridazino-quinolina.
ES2113368T3 (es) Antagonistas de serotonina.
ES2115058T3 (es) Derivados basicos de acido glutamico y acido aspartico como antagonistas de la gastrina o colecistoquinina.
ATE149554T1 (de) Abbeizmittel
ES2121389T3 (es) Derivados de alquildiamina sustituidos y su uso como antagonistas de taquiquinina.
ATE122371T1 (de) Verfahren zur herstellung von bitumen-kautschuk- zusammensetzungen.
ATE283256T1 (de) C-16 ungesätigte fp-selektive prostaglandin analoge
MX9306552A (es) Pirazolo[4,3-c]piridinas, procedimiento para su preparacion y su utilizacion como inhibidores de la reabsorcion de serotonina.
BR9608245A (pt) Derivados de piperazino como antagonistas de neurocinina
ES2070002T3 (es) Composiciones terapeuticas a base de derivados de 1,2-ditiol-3-tiona.
ES2162686T3 (es) Nuevos derivados carboxamidas ciclicos sustituidos por carboxi.
DE60225250D1 (de) Nahrungsmittelzusammensetzungen auf der Basis von mit Intensivsüssstoff vermischtem Kakao und deren Herstellungsverfahren

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 767783

Country of ref document: ES